Renaissance Technologies - PROTARA THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Renaissance Technologies ownership history of PROTARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$100
-50.0%
60,100
-28.1%
0.00%
Q2 2023$200
+8.7%
83,600
+41.9%
0.00%
Q1 2023$184
+2.2%
58,906
-12.1%
0.00%
Q4 2022$180
-99.9%
67,000
-15.4%
0.00%
Q3 2022$234,000
+47.2%
79,200
+46.1%
0.00%
Q2 2022$159,000
-17.2%
54,200
+44.1%
0.00%
Q1 2022$192,000
-56.1%
37,600
-42.0%
0.00%
-100.0%
Q4 2021$437,000
-45.5%
64,800
-44.1%
0.00%0.0%
Q3 2021$802,000
+60.1%
115,900
+125.4%
0.00%0.0%
Q2 2021$501,000
+1.4%
51,427
+63.8%
0.00%0.0%
Q1 2021$494,000
+19.3%
31,400
+83.5%
0.00%
Q4 2020$414,000
-34.9%
17,110
-54.7%
0.00%
-100.0%
Q3 2020$636,000
-27.6%
37,786
+26.0%
0.00%0.0%
Q2 2020$879,00029,9860.00%
Other shareholders
PROTARA THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Opaleye Management Inc. 2,692,594$8,077,8832.42%
Privium Fund Management (UK) Ltd 119,730$401,0960.32%
Ikarian Capital, LLC 188,664$584,8590.13%
Orbimed Advisors 793,558$2,483,8370.05%
Boxer Capital, LLC 209,227$6550.03%
Perceptive Advisors 290,051$907,8600.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 64,000$198,4000.01%
Baker Brothers Advisors 199,671$624,9700.00%
BOOTHBAY FUND MANAGEMENT, LLC 18,864$59,0440.00%
TWO SIGMA INVESTMENTS, LP 35,745$111,8820.00%
View complete list of PROTARA THERAPEUTICS INC shareholders